baber/WOPTO huggingface dataset:
Patent AU-697519-B2 (AU)
Title: Sheet perforation
Inventor: RIVA FRANCA
IPC: B26F1/24
Filed: 1997-10-14
Granted: 1998-10-08
Abstract: PCT No. PCT/GB93/01259 Sec. 371 Date Feb. 23, 1995 Sec. 102(e) Date Feb. 23, 1995 PCT Filed Jun. 17, 1993 PCT Pub. No. WO94/00278 PCT Pub. Date Jan. 6, 1994An apparatus for shaping perforations of sheet material which comprises a first mold structure at one side of the sheet material and a complementary mold structure at the other side of the sheet material to cooperate with the first mold structure wherein the structures are arranged to be reciprocated and are capable of meeting approximately half way through the sheet material whereby to shape the perforations between them. The apparatus can include a needle so that perforations are simultaneously formed and shaped, or it may be used to shape pre-formed perforations. If a needle is included it may be of the ultrasonic type or it may be heated, e.g. electrically heated. If a needle is used, one of the mold structures may be defined by an appropriate formation on the needle, or the structure may be separate.
Patent AU-721898-B2 (AU)
Title: Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
Inventor: LING NICHOLAS
IPC: A61P25/00
Filed: 1995-11-16
Granted: 2000-07-20
Abstract: Peptide analogues of human myelin basic protein containing residues 87-99 are provided. Residue 91 of the peptide analogues is altered from the L-lysine residue found in the native protein to any other amino acid. Pharmaceutical compositions of the peptide analogues are provided. In addition, the peptide analogues are administered to patients with multiple sclerosis.
Patent AU-572436-B2 (AU)
Title: Heat exchanger
Inventor: SOLBERG PER
IPC: F28D11/02
Filed: 1985-07-29
Granted: 1988-05-05
Abstract: PCT No. PCT/NO85/00045 Sec. 371 Date Mar. 20, 1986 Sec. 102(e) Date Mar. 20, 1986 PCT Filed Jul. 29, 1985 PCT Pub. No. WO86/01284 PCT Pub. Date Feb. 27, 1986.A heat exchanger (10) for indirectly heating, drying and cooling materials comprises a hollow rotor (40) having an inlet (46) of heating and cooling medium and an outlet (47) of the medium or its condensate, a casing mounted on the hollow rotor, a plurality of disc-shaped base boards (20), a plurality of annular ducts (21, 23; 22, 24) projected from both side surfaces (11, 12) of the base boards (20), the duct forming a passage communicating with the inlet (46) and the outlet (47), arranged so as to be partly superposed sequentially on both front and back surfaces (11, 12) of the base board (20) from the inner peripheral edges to the outer peripheral edges of the base boards (20) in such a manner that partition plates for shielding the ducts (21, 23; 22, 24) being provided in the superposed positions.
Patent AU-717218-B2 (AU)
Title: Medicinal combination useful for in vivo exogenic transfection and expression
Inventor: BACH JEAN-FRANCOIS
IPC: A61K35/76
Filed: 1996-02-12
Granted: 2000-03-23
Abstract: A medical combination of at least one immunosuppressive agent and at least one recombinant adenovirus with a genome that includes a first recombinant DNA containing a therapeutic gene, and a second recombinant DNA containing an immunoprotective gene, for consecutive, intermittent and/or simultaneous use in in vivo and/or ex vivo exogenic transfections.
Patent AU-779752-B2 (AU)
Title: Method for the identification and/or the quantification of a target compound
Inventor: REMACLE JOSE
IPC: C12Q1/68
Filed: 2000-05-16
Granted: 2005-02-10
Abstract: The present invention is related to a method for the identification and/or the quantification of a target compound obtained from a sample, preferably a biological sample, comprising the steps of putting into contact the target compound with a capture molecule in order to allow a specific binding between the target compound with a capture molecule, the capture molecule being fixed upon a surface of a solid support according to an array comprising a density of at least 20 discrete regions per cm<SUP>2</SUP>, each of the discrete regions being fixed with one species of capture molecules, performing a reaction leading to a precipitate formed at the location of the binding, determining the possible presence of precipitate(s) in discrete region(s), and correlating the presence of the precipitate(s) at the discrete region(s) with the identification and/or a quantification of the target compound.
Patent AU-620689-B2 (AU)
Title: Pf 1022 substance, method of producing same and anthelmintic composition containing same
Inventor: NIIDA MASASHI
IPC: C12P17/14
Filed: 1990-02-07
Granted: 1992-02-20
Abstract: A novel substance having anthelmintic activity, the PF 1022 substance, which is produced by cultivating a fungal strain capable of producing said substance and recovering said substance from the culture.
Patent AU-667966-B2 (AU)
Title: Silica sols, a process for the preparation of silica sols and use of the sols
Inventor: ANDERSSON KJELL
IPC: D21H17/68
Filed: 1993-08-11
Granted: 1996-04-18
Abstract: PCT No. PCT/SE93/00663 Sec. 371 Date Feb. 3, 1995 Sec. 102(e) Date Feb. 3, 1995 PCT Filed Aug. 11, 1993 PCT Pub. No. WO94/05596 PCT Pub. Date Mar. 17, 1994Silica sols with a high content of microgel and particles with a specific surface area within the range 300 to 700 m2/g, preferably 400 to 650 m2/g. The sols can be prepared by acidification or a water glass solution and alkalization at a certain dry content, alternatively to a certain pH. The sols are particularly suitable for use as additives in papermaking in combination with cationic polymers and especially in combination with cationic acrylamide based polymers.
Patent AU-687754-B2 (AU)
Title: Tachykinin antagonists
Inventor: HORWELL DAVID CHRISTOPHER
IPC: A61K31/381
Filed: 1993-08-12
Granted: 1998-03-05
Abstract: The invention concerns tachykinin antagonists. The compounds are nonpeptides which have utility in treating disorders mediated by tachykinins. Such disorders are respiratory, inflammatory, gastrointestinal, ophthalmic, allergies, pain, vascular, diseases of the central nervous system, and migraine. Methods of preparing compounds and novel intermediates are also included. <??>The compounds are expected to be especially useful in asthma and rheumatoid arthritis.
Patent AU-673696-B2 (AU)
Title: Quinolone and acridinone derivatives for the treatment of urinary incontinence
Inventor: OHNMACHT CYRUS JOHN
IPC: A61K31/44
Filed: 1993-10-14
Granted: 1996-11-21
Abstract: Compounds of Formula (I) wherein R<2>, R<3>, R<4>, R<10> and R<11> have any of the meanings given in the specification, and their pharmaceutically acceptable salts are useful in the treatment of urinary incontinence. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of Formula (I) and intermediates.
Patent AU-635529-B2 (AU)
Title: A cheese product
IPC: A23L9/20
Filed: 1990-04-10
Granted: 1993-03-25
Abstract: A cheese product having a low level of saturated fat and cholesterol, a high level of polyunsaturated fat and good organoleptic properties is prepared by adding a vegetable fat-based cream to skim, semi-skimmed or low fat milk to a cheese vat and processing using conventional techniques to form cheese. The cream is prepared by adding a blend of vegetable pasteurised oils such as soya oil and hydrogenated soya oil and an emulsifier to an aqueous phase comprising a pasteurised blend of water and a stabiliser such as gelatin. The fat-in-water emulsion thus formed is then blended and homogenised to form the cream.
Patent AU-697593-B2 (AU)
Title: Ultrahigh brightness calcined clay pigment, manufacture and use thereof
Inventor: FORBUS ELLEN S
IPC: C09C1/42
Filed: 1996-03-21
Granted: 1998-10-08
Abstract: A selected kaolin crude or crude fraction is purified by physical or physical/chemical means, such as froth flotation and/or selective flocculation, to remove discrete particles of TiO2 and in some cases, discrete iron minerals. The pure (or purified clay) must then be agitated in the presence of water with a particulate grinding media such as, for example, sand, alumina or zirconia beads, to increase the 2 micron content of the kaolin. An intermediate ground product that contains a substantial weight percentage of particles finer than 1 micron is generated as a result of grinding. The particles finer than 1 micron in the ground kaolin also include those particles in the previously pure or purified kaolin that were present in the naturally occurring clay. A pulp of the ground clay is then fractionated to remove particles larger than 2 microns, e.g., to remove at least 95%, preferably at 100% by weight, of the particles larger than 2 microns, while minimizing the removal of particles finer than 1 micron. The resulting fine particles size fraction is then treated by conventional series of steps, i.e., optional bleaching, drying, pulverization, calcination and repulverization to produce a low abrasion, ultrahigh brightness (typically 96%) calcined kaolin pigment.
Patent AU-727611-B2 (AU)
Title: Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
Inventor: SOREQ HERMONA
IPC: A61K38/00
Filed: 1997-12-12
Granted: 2000-12-14
Abstract: A synthetic nuclease resistant antisense oligodeoxynucleotide (AS-ODN) capable of selectively modulating human acetylcholinesterase (AChE) production and a composition comprising at least one AS-ODN as an active ingredient. A nuclease resistant antisense targeted against the splice junction in the AChE mRNA post-splice message is disclosed. The synthetic nuclease resistant AS-ODNs are capable of selectively modulating human AChE production in the central nervous system or capable of selectively reducing human AChE deposition of the neuromuscular junction. The present invention also provides a method to restore balanced cholinergic signalling in the brain and spinal cord or reduce AChE in the neuromuscular junction in patients in need of such treatment by administering to a patient in need of such treatment a therapeutically effective amount of at least one of the synthetic nuclease resistant AS-ODN capable of selectively modulating human AChE production.
Patent AU-641389-B2 (AU)
Title: Expression of human apolipoproteins AI-milano in yeast
Inventor: SIRTORI CESARE
IPC: A61K38/00
Filed: 1990-04-17
Granted: 1993-09-23
Abstract: An expression vector capable of expressing, in a transformed yeast, apolipoprotein AI and mutant apolipoprotein AI-M (Milano) is described. Yeast strains, namely of S.cerevisiae, transformed by said vectors, produce the protein which may be conveniently purified and used for the treatment of atherosclerosis and cardiovascular diseases.
Patent AU-716671-B2 (AU)
Title: Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome
Inventor: MARIN PER
IPC: A61K49/00
Filed: 1996-05-30
Granted: 2000-03-02
Abstract: The use of cortisol agonist for preparing a system for diagnosis of the Metabolic Syndrome and related conditions as belly fatness, insulin resistance including increased risk of developing senile diabetes, i.e., diabetes type II, high blood fats and high blood pressure, in which system the dose of cortisol agonist is in an interval where a difference is obtained in the inhibitory effect of the autoproduction of cortisol in individuals suffering from the Metabolic Syndrome, compared to normal values.
Patent AU-673235-B2 (AU)
Title: Collagen treatment apparatus and method
Inventor: SAND BRUCE J
IPC: A61B18/20
Filed: 1994-04-11
Granted: 1996-10-31
Abstract: Apparatus for shrinking collagen tissue includes means for generating radiation in a wavelength range of 1.80 to 2.55 microns. The radiation is delivered to the tissue in a controlled pattern in order to achieve selective shrinkage thereof. The radiation generator is conveniently a laser capable of generating coherent energy in the manner required.
Patent AU-767018-B2 (AU)
Title: Random number generator seeding method and apparatus
Inventor: MCLOUGHLIN BRUCE
IPC: G06F7/58
Filed: 1999-09-14
Granted: 2003-10-30
Abstract: A random number generator seeding method and apparatus which includes the provision of an RNG seed register and means for capturing a current count number from one or more fast running counters contained within the apparatus upon the occurrence of an act or acts by an apparatus operator as he performs the normal set-up and initialization function. In the preferred embodiment means are provided for sensing particular acts of the operator, and upon detection of each such "event", one or more of the counters within the system are read and the count value is appended to previously captured counter values until the desired seed length is obtained. At this time, the RNG is said to be seeded, the initialization phase is completed and the apparatus may be made available to players to commence game play or other use of the apparatus.
Patent AU-625509-B2 (AU)
Title: Plants with modified flowers
Inventor: GREEF WILLY DE
IPC: A01H5/10
Filed: 1990-08-09
Granted: 1992-07-16
Abstract: A plant, the nuclear genome of which is transformed with a foreign DNA sequence encoding a product which neutralizes the activity of another product which disrupts the metabolism, functioning and/or development selectively of the plant's flower cells, particularly reproductive organ cells, or seed cells or embryo cells. The foreign DNA sequence also optionally encodes a marker.
Patent AU-725302-B2 (AU)
Title: Amino acid ester containing azole antifungals
Inventor: MEERPOEL LIEVEN
IPC: C07D521/00
Filed: 1998-02-03
Granted: 2000-10-12
Abstract: The present invention concerns novel compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts thereof and stereochemically isomeric forms thereof, wherein -A-B- forms a bivalent radical of formula -N=CH- (a), -CH=N- (b), -CH=CH- (c), L represents the acyl moiety of an amino acid; D is an azole containing 1,3- or 1,4-dioxolane derivative as broad-spectrum antifungals; their preparation, compositions containing them and their use as a medicine.
Patent AU-586070-B2 (AU)
Title: Improved process for the preparation of dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione
Inventor: HOEKSTRA MARVIN SIMON
IPC: C07D487/04
Filed: 1987-02-24
Granted: 1989-06-29
Abstract: Dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione is produced in higher overall yield in a process which comprises catalytically hydrogenating a lower alkyl ester of 4-(hydroxyimino)heptanedioic acid in the presence of a tri-(lower alkyl)amine, followed by cyclization of the product thus produced in the presence of a cyclizing agent such as acetic anhydride.
Patent AU-676927-B2 (AU)
Title: Amino acid supplement
Inventor: LINDGREN SVANTE
IPC: A61K31/23
Filed: 1994-07-01
Granted: 1997-03-27
Abstract: The present invention relates to preparations to be used in therapy or nutrition containing stabilized or solubilized forms of amino acids otherwise unstable in solution or poorly soluble in aqueous fluids. The sensitive amino acids are included in the said preparations as glyceryl esters of compounds chosen among at least one amino acid and fatty acids.
Patent AU-660274-B2 (AU)
Title: Chemical solution dispensing and handling system
Inventor: COPELAND JAMES L
IPC: B01J4/02
Filed: 1991-01-15
Granted: 1995-06-22
Abstract: A dispensing and handling system for solutions is disclosed. The system includes a container (11) for mixing, storing and dispensing a use solution (44) through a spigot (17). The container (11) is mounted upon a cart (12), and is interconnected to a water supply conduit (16) and a concentrate solution tube (14). The concentrate solution (15) is contained within containers or bags (13). An aspirator (26) is permanently mounted within the storage container (11). The water conduit (16) and pick-up tube (14) are releasably connected to the storage container (11) by means of a quick-connect assembly (35). Also disclosed is a method for storing and handling solutions.
Patent AU-586924-B2 (AU)
Title: Magneto-optical recording apparatus
Inventor: HORIMAI HIDEYOSHI
IPC: G11B13/04
Filed: 1987-04-21
Granted: 1989-07-27
Abstract: A magnetooptical recording apparatus is disclosed which is capable of performing real-time overwrite operation. The apparatus comprises a laser beam (3) and focusing parts (4) thereof and a pulse magnetic field generator device (6) provided on both sides of a magnetooptical recording medium (1) respectively. The laser beam (3) and focusing parts (4) thereof are formed of an objective lens (5) connected to a moving coil (8) which is provided in a magnet (7), thus the objective lens (5) is movable relative to a magnetic layer (1A) of the magnetooptical recording medium (1) by the interaction between the magnet (7) and the moving coil (8). The magnet (7) generates and applies a D.C. magnetic field of one polarity perpendicular to the magnetic thin film (1A) around a point (P) where the laser beam (3) is focused. While the pulse magnetic field generator device (6) generates pulse magnetic field of the opposite polarity modulated by information signal around the point (P) where the laser beam (3) is focused. Thus one and opposite polarity magnetic field pulse row obtained by a sum of the D.C. magnetic field and the pulse magnetic field is applied to the magnetic thin film (1A) upon laser beam (3) irradiation to perform the real-time overwrite operation.
Patent AU-740910-B2 (AU)
Title: Device for connecting two components
Inventor: HASLER GEORG
IPC: F16B12/20
Filed: 1998-06-22
Granted: 2001-11-15
Abstract: The bonding unit (1) to lock two components together, especially furniture boards, has an inserted pot component (2) and a rotating operating unit (4) to hold the connection in the pot, which can be operated from the outside such as by a screwdriver (11). A guide channel (13), in the pot, may be at an angle to the rotary axis (3) of the operating unit, and aligned to it, through an outer wall of the pot structure. The guide channel may be built through a clearance hole in an outer wall (17) of the insert pot component.
Patent AU-639538-B2 (AU)
Title: Contact lens casting mould
IPC: B29C33/40
Filed: 1991-03-18
Granted: 1993-07-29
Abstract: A mould for casting contact lenses comprises two casting mould halves. On a female mould part (1) there is formed a concave moulding surface (11) and on a male mould part (2) there is formed a convex moulding surface (21). The two joined casting mould halves (1 and 2) hold together by frictional connection. <IMAGE>
Patent AU-634361-B2 (AU)
Title: High pressure facilitated membranes for selective separation and process for the use thereof
IPC: B01D53/22
Filed: 1991-03-28
Granted: 1993-02-18
Abstract: A process for the selective separation of at least one component eg propylene of a gaseous feedstream comprises passing the feedstream containing the component through a separation unit (50), the separation unit (50) containing a porous membrane (53), eg in the form of a hollow fiber, the membrane (53) having a feed side and a permeate side, and a pore size of from about 10 Angstroms to about 200 Angstroms. Disposed in the pores of the porous membrane (53) is a facilitator liquid comprising a carrier eg silver nitrate dissolved in a suitable solvent. The process includes the steps of   (a) dissolving the component in the facilitator liquid on the feed side of the porous membrane (53) at the feed gas/membrane interface;   (b) forming a component-carrier complex; (c) diffusing the complex to the permeate side of the porous membrane (53): and   (d) releasing the component from the carrier.   <IMAGE>
Patent AU-691826-B2 (AU)
Title: Improved nicotine lozenge and therapeutic method for smoking cessation
Inventor: SANTUS GIAN CARLO
IPC: A61P25/30
Filed: 1994-07-20
Granted: 1998-05-28
Abstract: A method for smoking cessation therapy is described that is utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a non-nutritive sweetener and an absorbent excipient.
Patent AU-614714-B2 (AU)
Title: Human monoclonal antibody to lymphadenopathy-associated virus
Inventor: MCCLURE JANELA
IPC: G01N33/569
Filed: 1987-06-19
Granted: 1991-09-12
Abstract: Human monoclonal antibodies capable of specifically reacting with an antigenic determinant of LAV/HTLV-III and cell lines producing those monoclonal antibodies are disclosed. The human monoclonal antibodies may be utilized in a method for determining the presence of LAV/HTLV-III in biological samples, or in a method for separating specific antigenic determinants of LAV/HTLV-III from a mixture. Pharmaceutical compositions containing such a human monoclonal antibody, and a method for significantly reducing the infectivity of LAV/HTLV-III in animals using the composition are also disclosed.
Patent AU-633431-B2 (AU)
Title: Suction transfer assembly
IPC: A61J1/00
Filed: 1991-05-14
Granted: 1993-01-28
Abstract: A suction transfer assembly (1) for a medicament liquid (L), especially a hazardous liquid, that permits safe and easy transfer of liquid (L) from its container to a suction operating dispenser device such as a syringe (60), yet avoids leakage on detaching the device from the assembly, comprises a longitudinal vial (10) and longitudinal adapter (30). The vial (10) forms an enclosed longitudinal chamber (14) filled with the medicament liquid (L) and has an open end (13) closed by a penetrable stopper (15). The vial (10) is slidable longitudinally relative to the stopper (15) and the stopper (15) seals the liquid (L) in the chamber (14). The stopper (15) has fastening means (19) facing the vial open end (13). The adapter (30) has front (31) and rear (32) ends and an internal flow path (33) extending therethrough. The rear end (32) has a rearwardly facing hollow needle (36) with a pointed tip (37) defining the flow path (33) rear terminus, and fastening means (38). The rear end (32) is insertable into the vial open end (13) to fasten the adapter fastening means (38) to those of the stopper (15) and to penetrate the stopper (15) by the needle (36) so as to connect the chamber (14) and flow path (33). The adapter front end (31) has a forwardly facing hollow nozzle (39) defining the flow path (33) front terminus, a self-closing check valve (40) in the flow path (33) adjacent the nozzle (39), and a lock connector (45). A suction device (60) can be locked to the adapter (30) so as to open the check valve (40). Suction operation of the device (60) will cause liquid transfer from the chamber (14) via the adapter (30) to the device (60) and simultaneous compensating vial (10) movement longitudinally relative to the stopper (15) under external atmospheric pressure to reduce the chamber (14) volume by an amount generally equal to the liquid transferred. <IMAGE>
Patent AU-740659-B2 (AU)
Title: Screwdriver with dual cam slot for collated screws
Inventor: HABERMEHL G LYLE
IPC: F16B27/00
Filed: 1998-06-19
Granted: 2001-11-08
Abstract: A screwdriver for driving collated screws including a slide body coupled to a housing for reciprocal displacement in a cycle including a retraction stroke and an extension stroke. A lever pivotably mounted to the slide body carries at one end a cam pin received in a cam slot in the housing with the other end of the lever advancing successive screws in the screwstrip, the cam slot having first and second camming surfaces for selective engagement by the cam pin to vary the relative positionning of the lever to be different for the same position if the slide body in the housing in the retraction strokes than in the extension stroke.